%D9%85%D8%B3%D8%AA%D8%B4%D9%81%D9%89_%D9%87%D8%A7%D9%8A%D8%AF%D9%84%D8%A8%D8%B1%D8%BA_%D8%A7%D9%84%D8%AC%D8%A7%D9%85%D8%B9%D9%8ACategory:Universit%C3%A4tsklinikum_HeidelbergUniversit%C3%A4tsklinikum_HeidelbergUniversity_Hospital_HeidelbergHospital_Universitario_de_HeidelbergCentre_hospitalier_universitaire_de_HeidelbergHeidelbergi_Egyetemi_K%C3%B3rh%C3%A1zQ324206
about
Ernst Gustav JungJürgen DebusMichel WensingSteeve BoulantTorsten SchallerKiran K BaliMichael AllgäuerKai BreuhahnPhilipp KickingerederNico T MuttersJulio Saez-RodriguezAndré HennigsAndré SchütteJan-Henning KlusmannDaniel ParthierSevin TurcanMichael BoettcherSusanne BonekampMarkus RiesStefan SchönlandDerliz MerelesMartin PfannmöllerViet Loan Dao ThiFabian aus dem SiepenDaniel E StangeJan LarmannMax DinklerJuan Pablo RigalliStephanie BauerStefan PuschRobert F OfenlochChristian FischerMartin Jean KochErik JungIart Luca ShytajSilvia PortugalMirko CorteseBenjamin LeblancFelix NickelKarl-Friedrich Kowalewski
P108
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic LeukemiaStudy of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)Strategic Timing of Antiretroviral TreatmentCytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaPyruvate Kinase Deficiency Global Longitudinal RegistryA Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and RefracSafety and Efficacy of KTE-C19 in Adults With Relapsed/Refractory Chronic Lymphocytic LeukemiaA Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Refractory Multiple MyelomaRituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaFludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
P6153
Q20742633-409f2f6e-49cf-2928-405f-d7616c69dd44Q20742688-88c0cef1-4363-8f5d-eebc-6cf8fea05106Q28324296-B0DC05D8-1D69-479D-8506-CB28EE1F0558Q29460031-4F1F26D5-2D9B-4578-A858-7D195422FB06Q30509834-C6EBB9EA-39BD-4ACF-A10B-627C9D50C782Q30746466-FEECE040-2F7A-4DFE-B96A-84AECD9AB754Q37372952-54442840-561E-48EC-9F34-A606B1E5A0D4Q40112503-91c2e369-467e-d3f8-85b3-f50bd262450fQ40394749-CFB89021-E6F1-4C82-9B72-60A03DEA3C55Q40466855-CAA1EFD3-7470-4494-8905-0E6E6EE92DCCQ41044850-EC30F4B3-8BCB-4C32-BB9D-D937DD50B1AEQ41489113-67A5F4C5-4663-411F-8877-7D4672D1C62CQ42175321-76D0166D-FB1D-4A4B-989A-8BAC57EC5B18Q42231158-C874D466-2D89-4F26-8CB4-DA35C9F29FC8Q42550243-2D7F218F-71DA-40FE-A839-773CB6DF8030Q42574772-C16A6610-CE59-4AA1-B8EE-CD563E78F0AAQ42602187-01D771FC-F5C7-48FF-B110-DC3270E1D6DBQ42652788-9A33006B-9822-4AAB-B89E-3AA238D7CCC3Q43185408-A375CF4F-03EB-48E7-B53F-38F04880234EQ47114671-0E3F539D-8DC2-4D24-9579-023E52DEF333Q47114678-B30680AC-DC5F-437B-B161-ABC467047E10Q48255161-03550B7D-B7BF-485E-8859-F4E38810E857Q48255161-AE84873C-4EB3-42D8-AD6A-226E9681AC64Q50285716-E28CF628-70B1-4B99-8F2A-85B3DCAEAA85Q50437161-03501747-1744-45DB-B459-0F1C62D5ADE5Q50614561-2AE09F1A-0DAD-41DB-B16E-AEF09CD5D3C4Q50716185-DCA3E4B3-574C-47C1-A0A9-99A3CF1B43A7Q50828055-b988d03e-4108-3386-656d-dbb867cf47b4Q50888430-C03A14CA-1745-4854-A3B3-958EF8C32EB8Q50972519-6751733A-337B-4BE8-9001-51C395D7487DQ51075545-F66F4E1D-2AA4-41D0-909E-5ECF21CEDDBAQ51076350-7BBD3334-8567-4A62-8EEB-71E22AD11613Q51311256-B44A9032-DE7D-42F5-8709-EB330102CC9FQ51311256-EC2A0D96-4F6C-420A-832E-BE9A75ACD8B1Q51702449-6A3C6CC5-AB7E-4D62-ADE0-06C76C38D26EQ52147248-6DF53896-46F2-4952-8912-FEB4DC3C975EQ55136352-30C8E278-B31A-4022-90C5-91F354CC40E7Q55176191-A3BEFDD8-3582-49BE-A1CC-8EDF37AE0147Q55186628-7AF1B5F3-7D55-4B63-B859-44FB96E11CA9Q55458627-F94401A0-E1DA-47BA-AF13-5D6329139241
P108
Q61915467-F4001C27-6656-45C4-AB45-D4B9703BF2B6Q61938394-0B86BA4E-9B1C-4088-9CF9-CD05C08085E4Q61980931-986F2801-E663-4729-8D1E-3A0BCC6C218BQ62105041-A72F4BC1-D945-4E17-8A7E-F3908923106FQ62811048-D5E7EC88-E77C-449C-9EF1-AF58CCE041C4Q63339113-9DF8FF00-7C39-4271-A0AD-EC0E219978CCQ63393836-BA84AB73-768E-4CB0-9C82-667721BEE5DBQ63577771-34B33875-4998-4C6D-BDEA-54CF2865C104Q64171007-0AAB8C33-E66E-4339-9F00-CBF4B4207B7FQ64171007-250A7739-904C-44C5-81A9-E9415FFA93C5Q64171011-0426BB82-979B-4267-86A0-1FE434C8A25D
P6153
Q29983306-a6785a3b-4c2b-c914-6c72-e31a729ebe1cQ48805583-53211277-0E8E-4321-B971-958012B51771Q56256988-F48AABCB-56FC-480C-B227-20C1EB26BF54Q57169635-482C2CCB-1FEE-4381-8901-174CB62D98C7Q59694887-BF692A1C-9486-4FA5-8925-4E544F0A101FQ60976340-F54832AC-7093-4F01-B831-E94C45E84FB2Q61912524-8f6eac77-461f-210f-b434-203e7b24d743Q63860305-51db3d64-4019-d484-f125-584bb8014f8c
P69
description
Krankenhaus in Deutschland
@de
heidelberg university hospital
@ru
hospital in Germany
@en
hôpital
@fr
rumah sakit di Jerman
@id
ziekenhuis in Duitsland
@nl
בית חולים בגרמניה
@he
مستشفى
@ar
병원
@ko
name
Heidelbergi Egyetemi Kórház
@hu
Hospital Universitario de Heidelberg
@es
University Hospital Heidelberg
@en
Universitätsklinikum Heidelberg
@de
centre hospitalier universitaire de Heidelberg
@fr
مستشفى هايدلبرغ الجامعي
@ar
ハイデルベルク大学病院
@ja
海德堡大学附属医院
@zh
海德堡大学附属医院
@zh-cn
海德堡大学附属医院
@zh-hans
type
label
Heidelbergi Egyetemi Kórház
@hu
Hospital Universitario de Heidelberg
@es
University Hospital Heidelberg
@en
Universitätsklinikum Heidelberg
@de
centre hospitalier universitaire de Heidelberg
@fr
مستشفى هايدلبرغ الجامعي
@ar
ハイデルベルク大学病院
@ja
海德堡大学附属医院
@zh
海德堡大学附属医院
@zh-cn
海德堡大学附属医院
@zh-hans
altLabel
CHU d'Heidelberg
@fr
CHU de Heidelberg
@fr
Medizinische Fakultät Heidelberg
@de
Uniklinik Heidelberg
@de
Universitätsklinik Heidelberg
@de
海德堡大学医院
@zh
海德堡大學醫院
@zh-hant
prefLabel
Heidelbergi Egyetemi Kórház
@hu
Hospital Universitario de Heidelberg
@es
University Hospital Heidelberg
@en
Universitätsklinikum Heidelberg
@de
centre hospitalier universitaire de Heidelberg
@fr
مستشفى هايدلبرغ الجامعي
@ar
ハイデルベルク大学病院
@ja
海德堡大学附属医院
@zh
海德堡大学附属医院
@zh-cn
海德堡大学附属医院
@zh-hans
P355
P214
P227
P244
P2581
P6366
P646
P131
P213
0000 0001 0328 4908
P214
P227
P2427
grid.5253.1
P244
n2011184429